Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria
| Autor: | Gustavo Deza, Thomas B. Casale, Ana Giménez-Arnau, Peter A. Ricketti |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Urticaria Disease Omalizumab 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Humans Immunology and Allergy media_common.cataloged_instance Medical history European union Intensive care medicine Depression (differential diagnoses) media_common Angioedema business.industry Natural history 030228 respiratory system Chronic Disease Anxiety medicine.symptom business Biomarkers medicine.drug |
| Zdroj: | The Journal of Allergy and Clinical Immunology: In Practice. 6:1108-1117 |
| ISSN: | 2213-2198 |
| DOI: | 10.1016/j.jaip.2018.02.024 |
| Popis: | Chronic spontaneous urticaria (CSU) is defined as the appearance of evanescent wheals, angioedema, or both, for at least 6 weeks. CSU is associated with intense pruritus and poor quality of life, with higher odds of reporting depression, anxiety, and sleep difficulty. As of yet, the assessment of the activity and course of the disease along with the response to several treatments in CSU are based purely on the patient's medical history and the use of the patient-reported outcomes. Recently, several reports have suggested that certain parameters could be considered as potential disease-related biomarkers. Moreover, with the advent of such biomarkers, newer biologic agents are coming forth to revolutionize the management of potential refractory diseases such as CSU. The purpose of this article is to review the most promising biomarkers related to important aspects of CSU, such as the disease activity, the therapeutic response, and the natural history of the disease, and discuss the mechanisms of action and therapeutic effectiveness of the latest agents available or currently under investigation for the management of antihistamine-refractory CSU. The knowledge of these features could have an important impact on the management and follow-up of patients with CSU. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|